Thomas DL - Search Results

1

Severity and correlates of liver disease in hepatitis C virus-infected injection drug users.

Rai R, Wilson LE, Astemborski J, Anania F, Torbenson M, Spoler C, Vlahov D, Strathdee SA, Boitnott J, Nelson KE, Thomas DL. Rai R, et al. Among authors: thomas dl. Hepatology. 2002 May;35(5):1247-55. doi: 10.1053/jhep.2002.33151. Hepatology. 2002. PMID: 11981775

2

Correlates of hepatitis C virus infections among injection drug users.

Thomas DL, Vlahov D, Solomon L, Cohn S, Taylor E, Garfein R, Nelson KE. Thomas DL, et al. Medicine (Baltimore). 1995 Jul;74(4):212-20. doi: 10.1097/00005792-199507000-00005. Medicine (Baltimore). 1995. PMID: 7623656 Free article. Review.

3

Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases.

Thomas DL, Cannon RO, Shapiro CN, Hook EW 3rd, Alter MJ, Quinn TC. Thomas DL, et al. J Infect Dis. 1994 May;169(5):990-5. doi: 10.1093/infdis/169.5.990. J Infect Dis. 1994. PMID: 8169429

4

Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users.

Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, Hoover DR, Cheung L, Nelson KE. Thomas DL, et al. J Infect Dis. 1996 Oct;174(4):690-5. doi: 10.1093/infdis/174.4.690. J Infect Dis. 1996. PMID: 8843204

5

Seroreactivity to hepatitis E virus in areas where the disease is not endemic.

Thomas DL, Yarbough PO, Vlahov D, Tsarev SA, Nelson KE, Saah AJ, Purcell RH. Thomas DL, et al. J Clin Microbiol. 1997 May;35(5):1244-7. doi: 10.1128/jcm.35.5.1244-1247.1997. J Clin Microbiol. 1997. PMID: 9114415 Free PMC article.

6

Persistence and clinical significance of hepatitis G virus infections in injecting drug users.

Thomas DL, Nakatsuji Y, Shih JW, Alter HJ, Nelson KE, Astemborski JA, Lyles CM, Vlahov D. Thomas DL, et al. J Infect Dis. 1997 Sep;176(3):586-92. doi: 10.1086/514078. J Infect Dis. 1997. PMID: 9291303

7

Hepatitis A among homosexual men and injection drug users: more evidence for vaccination.

Villano SA, Nelson KE, Vlahov D, Purcell RH, Saah AJ, Thomas DL. Villano SA, et al. Among authors: thomas dl. Clin Infect Dis. 1997 Sep;25(3):726-8. doi: 10.1086/513757. Clin Infect Dis. 1997. PMID: 9314468

8

Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing.

Erbelding EJ, Vlahov D, Nelson KE, Rompalo AM, Cohn S, Sanchez P, Quinn TC, Brathwaite W, Thomas DL. Erbelding EJ, et al. Among authors: thomas dl. J Infect Dis. 1997 Nov;176(5):1397-400. doi: 10.1086/517330. J Infect Dis. 1997. PMID: 9359747

9

Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.

Villano SA, Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL. Villano SA, et al. Among authors: thomas dl. J Clin Microbiol. 1997 Dec;35(12):3274-7. doi: 10.1128/jcm.35.12.3274-3277.1997. J Clin Microbiol. 1997. PMID: 9399533 Free PMC article.

10

Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection.

Thomas DL, Vlahov D, Alter HJ, Hunt JC, Marshall R, Astemborski J, Nelson KE. Thomas DL, et al. J Infect Dis. 1998 Mar;177(3):539-42. doi: 10.1086/514245. J Infect Dis. 1998. PMID: 9498429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

769 results

Search Page

Filters